Cargando…
An Unusual Prostate-Specific Antigen Decrease in an Advanced Castration-Resistant Prostate Cancer Patient with Intracerebral Hemorrhage Subsequently Treated with Luteinizing Hormone-Releasing Hormone Antagonist
An unusual prostate-specific antigen (PSA) decrease in a Japanese patient with advanced castration-resistant prostate cancer (CRPC) treated with luteinizing hormone-releasing hormone (LH-RH) antagonist after cerebral bleeding was presented. There have been no previous reports that cerebral bleeding...
Autores principales: | Izumi, Kouji, Mizokami, Atsushi, Namiki, Mikio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924709/ https://www.ncbi.nlm.nih.gov/pubmed/24570683 http://dx.doi.org/10.1159/000357668 |
Ejemplares similares
-
Late-Onset Capsular Block Syndrome: Unusually Delayed Presentation
por: Rana, M., et al.
Publicado: (2013) -
Optimal treatment for castration-resistant prostate cancer
por: Izumi, Kouji, et al.
Publicado: (2014) -
Primary Retroperitoneal Müllerian Adenocarcinoma: A Case Report and Literature Review
por: Spinelli, C., et al.
Publicado: (2013) -
Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels
por: Czejka, M., et al.
Publicado: (2013) -
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
por: Quack, Henriette, et al.
Publicado: (2013)